Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa) Meeting Abstract
| Authors: | Wagner, A. J.; Riedel, R. F.; Van Tine, B. A.; Chugh, R.; Ganjoo, K. N.; Cranmer, L. D.; Pollack, S.; Sankhala, K. K.; Gordon, E. M.; Ravi, V.; Hornick, J. L.; Kwiatkowski, D. J.; Grigorian, B.; Desai, N.; Dickson, M. A. |
| Abstract Title: | Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 598s |
| Language: | English |
| ACCESSION: | WOS:000442916008050 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS11589 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract : TPS11589 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
